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Abstract
We previously showed that fusion between hepatocytes lacking a crucial liver enzyme, fumarylacetoacetate hydrolase
(FAH), and wild-type blood cells resulted in hepatocyte reprogramming. FAH expression was restored in hybrid hepatocytes
and, upon in vivo expansion, ameliorated the effects of FAH deficiency. Here, we show that fusion-derived polyploid
hepatocytes can undergo ploidy reductions to generate daughter cells with one-half chromosomal content. Fusion hybrids
are, by definition, at least tetraploid. We demonstrate reduction to diploid chromosome content by multiple methods. First,
cytogenetic analysis of fusion-derived hepatocytes reveals a population of diploid cells. Secondly, we demonstrate marker
segregation using ß-galactosidase and the Y-chromosome. Approximately 2–5% of fusion-derived FAH-positive nodules
were negative for one or more markers, as expected during ploidy reduction. Next, using a reporter system in which ß-
galactosidase is expressed exclusively in fusion-derived hepatocytes, we identify a subpopulation of diploid cells expressing
ß-galactosidase and FAH. Finally, we track marker segregation specifically in fusion-derived hepatocytes with diploid DNA
content. Hemizygous markers were lost by $50% of Fah-positive cells. Since fusion-derived hepatocytes are minimally
tetraploid, the existence of diploid hepatocytes demonstrates that fusion-derived cells can undergo ploidy reduction.
Moreover, the high degree of marker loss in diploid daughter cells suggests that chromosomes/markers are lost in a non-
random fashion. Thus, we propose that ploidy reductions lead to the generation of genetically diverse daughter cells with
about 50% reduction in nuclear content. The generation of such daughter cells increases liver diversity, which may increase
the likelihood of oncogenesis.
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Introduction
Cell divisions in mitosis are thought to always produce daughter
cells with the same chromosome content as the parental cell. Our
recent studies with fusion-derived polyploid hepatocytes challenge
that ideology. We propose that polyploid hepatocytes can undergo
ploidy reductions, leading to the generation of genetically distinct
daughter cells with reduced DNA content.
Our group previously showed that transplantation of wild-type
bone marrow into fumarylacetoacetate hydrolase (Fah) knockout mice
leads to the generation of fusion-derived hepatocytes [1,2]. In this
murine model for the human disease hereditary tyrosinemia type
1, hepatocytes expressing FAH have a strong selective growth
advantage and can repopulate the diseased host liver [3,4]. Fah
2/2
mice can be bred and kept healthy by administering the drug 2-(2-
nitro-4-trifluoro-methylbenzol)-1,3-cyclohexanedione (NTBC) in
their drinking water [5]. This drug blocks tyrosine catabolism
upstream of FAH and, therefore, prevents the accumulation of
fumarylacetoacetate, the toxic substrate of FAH. NTBC with-
drawal induces liver injury and results in death from liver failure
4–8 weeks later. In bone marrow transplanted Fah
2/2 mice, fusion
between the Fah
+/+ donor blood cells and Fah
2/2 host hepatocytes
results in polyploid cells that have a selective advantage and can
completely repopulate the liver [1,2,6]. Furthermore, FAH
positive hepatocytes can be serially transplanted into secondary
and tertiary Fah
2/2 recipients, thereby expanding the pool of
hybrid hepatocytes and making them amenable to extensive
genetic and cell biological analysis [3,7]. Bone marrow transplan-
tation has been shown to generate fusion-derived hepatocytes by
numerous investigators [8–12]. However, direct differentiation of
hematopoietic precursors into liver epithelial cells cannot be
excluded, but it is clear that the majority of fusion-derived
hepatocytes arise by fusion of donor blood cells with preexisting
hepatocytes [1,2,6].
In our previous studies, chromosomal analysis of hepatocytes
from bone marrow transplanted mice revealed the presence of
diploid fusion-derived hepatocytes [1]. This result was surprising
since fusion-derived cells should be at least tetraploid. Thus, we
hypothesized that fusion-derived hepatocytes could undergo ploidy
reductions during regeneration, leading to genetic diversity among
daughter cells.
The present study rigorously examines whether fusion-derived
hepatocytes undergo ploidy reductions. First, cell fusion experi-
ments show conclusively that fusion-derived polyploid hepatocytes
generate daughter cells with one-half DNA content. Unexpectedly,
a high degree of aneuploidy was seen among fusion-derived cells.
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dent marker segregation. Hepatocytes derived by cell fusion were
expected to retain markers from each cell participating in the
fusion event. Indeed, analysis of liver sections from repopulated
mice showed the majority of nodules harboring both donor and
host markers. However, we also detected a low (but highly
reproducible) percentage of FAH positive nodules lacking
additional markers. Third, to exclude the possibility that diploid
hepatocytes expressing donor markers arose from transdifferentia-
tion of hematopoietic cells, we employed a Cre-loxP reporter
system in which ß-galactosidase (ß-gal) was only expressed in
hepatocytes generated though cell fusion. As expected, polyploid
hepatocytes expressed ß-gal and FAH. Consistent with the
cytogenetic results, hepatocytes with diploid DNA content also
expressed ß-gal and FAH. Finally, we tested individual cells for
donor and host markers. Single cell PCR analysis of diploid
daughter cells revealed a heterogeneous population containing a
combination of donor and host markers. Taken together, our
results demonstrate that fusion-derived polyploid hepatocytes
undergo ploidy reduction events, generating heterogeneous
populations of lower ploidy daughter cells.
Results
Fusion-Derived Hepatocytes Generate Daughter Cells
with One-Half DNA Content
Cell fusion produces hybrids with increased centrosome and
chromosome numbers. Numerous studies have suggested that
tetraploidy and aberrant centrosome numbers can result in genetic
instability and cancer [13,14]. To test whether hepatocytes
generated by cell fusion in vivo are genetically stable, we karyotyped
hepatocytes from serially transplanted mice. Lethally irradiated
Fah
2/2 recipients were transplanted with cKit
+ Lin
neg/lo Sca1
+
(KLS) bone marrow cells from wild-type or ROSA26 (lacZ
Tg/0)
donors in a sex-mismatched fashion. Following NTBC withdrawal
and liver repopulation, hepatocytes were serially transplanted into
female Fah
2/2 recipients, allowing fusion-derived hepatocytes to
undergo successive rounds of proliferation (Figure 1A). Impor-
tantly, only FAH positive cells (i.e., fusion products) but not Fah
2/2
hepatocytes can repopulate secondary recipient livers [3]. After
completed repopulation, unselected hepatocyte metaphases were
analyzed by standard G-banding techniques. Fusion between two
diploid cells generates a tetraploid cell. Normal hepatocytes
polyploidize in an age-dependent manner and can be diploid,
tetraploid, octaploid or higher (reviewed in [13]). Therefore, the
chromosome content of hybrid cells arising from hepatocyte-blood
fusion must be tetraploid or greater.
The chromosome content of fusion-derived hepatocytes (i.e.,
positive for Y-chromosome) varied widely (Figure 1B). Approxi-
mately 15% of the metaphases had exactly 80 chromosomes with
the percentage increasing to 30% of metaphases harboring nearly
80 chromosomes (8065). Furthermore, 9% of metaphases had
exactly 40 chromosomes, and the percentage increased to 14%
containing nearly 40 chromosomes (4064). The presence of
diploid and nearly diploid fusion-derived hepatocytes suggests that
they were produced by ploidy reduction events of tetraploid fusion
products. Fusion hepatocytes with intermediate numbers of
chromosomes were also found (.40 and ,80, .80 and ,160)
(Figure 1B). Nearly all of the Y-chromosome containing
metaphases had numerical chromosome abnormalities (Table 1).
These numerical aberrations may have resulted from the fusion
process or by DNA damage sustained by Fah
2/2 hepatocytes
during NTBC withdrawal [15].
The distribution of chromosomes among fusion-derived hepa-
tocytes clearly supported a pattern of cell fusion, ploidy reduction
and polyploidization (Figure 1C). For example, fusion between a
female diploid blood cell (40,XX) and male diploid hepatocyte
(40,XY) results in a tetraploid fusion-derived hepatocyte
(80,XXXY). A ploidy reduction event generates two types of
daughter cells (40,XY and 40,XX) that can polyploidize, giving
rise to tetraploid cells (80,XXYY and 80,XXXX, respectively).
Because we could not distinguish between daughter cells that lost
the Y-chromosome and host female hepatocytes, we focused
exclusively on Y-chromosome positive metaphases. Fusion-derived
tetraploid hepatocytes (,80,XXXY) were detected in 21% of the
metaphases analyzed. Approximately 14% of Y-chromosome
positive metaphases were nearly diploid (,40,XY), corresponding
to daughter cells arising through ploidy reduction. Furthermore,
8% of cells were ,80,XXYY, which is the expected karyotype for
polyploidized diploid cells.
In addition to finding fusion-derived hepatocytes arising from
diploid-diploid cell fusion, we detected cells generated by fusion
between male tetraploid hepatocytes (80,XXYY) and female
diploid blood cells (40,XX). Hexaploid cells (120,XXXXYY) were
detected in 17% of the metaphases. Furthermore, triploid cells
(either ,60,XYY or XXY), which are the predicted daughter cells
of hexaploid reduction events, were identified in 17% of
metaphases. Together, these data strongly support the emergence
of daughter cells containing one-half DNA content from fusion-
derived hepatocytes. Similar to normal diploid hepatocytes,
diploid daughter cells either remain diploid or polyploidize to
generate tetraploid hepatocytes.
Marker Segregation in Fusion-Derived Hepatocytes
After demonstrating that fusion-derived hepatocytes could
generate daughter cells with one-half chromosome content, we
hypothesized that ploidy reduction events should also lead to
marker segregation amongdaughter cells.If ploidyreductionoccurs
in a tetraploid fusion-derived hepatocyte, there is a 50% chance of
losing a heterozygous or hemizygous marker. Liver sections from
mice repopulated by fusion-derived hepatocytes in serial transplan-
tation experiments (Figure 1A) were stained for FAH, Y-
chromosome and ß-gal activity (Figures 2A–2D). Typically, FAH
is co-expressed with the Y-chromosome (Figure 2A) and ß-gal
(Figure 2D). However, while most regenerating nodules expressed
all markers of cell fusion, a fraction of FAH positive nodules (2–5%)
were Y-chromosome negative (Figures 2B and 2C) or ß-gal negative
(Figure 2D). Based on the expected loss-of-heterozygosity frequency
Author Summary
The liver comprises many different types of cells, including
hepatocytes. Hepatocytes perform numerous physiologi-
cal functions, such as detoxification, metabolism, and
protein synthesis. Hepatocytes have the ability to fuse with
blood cells, generating hybrid hepatocytes that contain
nuclei from both fusion partners. In cases of genetic liver
disease, fusion between diseased hepatocytes and normal
blood cells can result in the formation of hybrid
hepatocytes that function normally. In this series of
experiments, we show that fusion hepatocytes produce
daughter cells with one-half the amount of DNA found in
the parental fusion hepatocyte. Furthermore, we show
that the daughter cells are genetically distinct from each
other. The increase in genetic diversity within the liver
could give rise to hepatocytes lacking proper growth
control, potentially resulting in tumor formation and
cancer.
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positive nodules were initiated by cells that had undergone ploidy
reductions.
Heterogeneous FAH positive nodules (lacking one or more
donor markers) were consistently found in repopulated mice
(Figure 2E). Similar results were obtained regardless of the
transplantation scheme (F.M.Fo rM .F.F). Approximately
25–50% of primary recipients contained Y-chromosome negative
FAH positive nodules, and this number increased to 90–100% of
secondary recipients. ß-gal negative FAH positive nodules were
seen in all serially transplanted mice analyzed. These data
demonstrate that ploidy reduction events leading to the formation
of heterogeneous daughter cells occur in a large fraction of livers
repopulated by fusion-derived hepatocytes.
Ploidy Reduction in Fusion-Derived Hepatocytes
To facilitate the genetic analysis of fusion-derived hepatocytes, a
Cre-loxP system was used to track fusion products. Fah
2/2 mice
Figure 1. Hepatocyte-blood fusion generates fusion-derived hepatocytes and associated daughter cells. (A) Serial transplantation
scheme for expansion of fusion-derived hepatocytes. KLS cells from female Fah
+/+ mice were transplanted into lethally irradiated Fah
2/2 male mice.
Following liver repopulation, hepatocytes were isolated from primary hosts and serially transplanted into Fah
2/2 female mice (F.M.F).
Alternatively, male KLS cells from ROSA26 mice (lacZ
Tg/0) were transplanted into female recipients and subsequently serially transplanted into Fah
2/2
female mice (M.F.F). (B and C) Hepatocytes from serially transplanted mice (F.M.F) were karyotyped (n=62 karyotypes from 4 transplanted
mice). The distribution of Y-chromosome positive hepatocytes is shown (B). Fusion events between hepatocytes and blood cells gave rise to fusion-
derived hepatocytes, which, in turn, underwent ploidy reductions (C). A fraction of reduced-ploidy daughter cells polyploidized. Parentheses indicate
the percentage of metaphases scored with the indicated chromosome content.
doi:10.1371/journal.pgen.1000385.g001
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a hepatocyte-specific albumin promoter (Alb-Cre) [16]. Lethally-
irradiated recipient mice were transplanted with bone-marrow
from a ROSA26 reporter (R26R) mouse (Figure 3A) [17]. These
animals harbor a floxed allele of the lacZ gene at the ROSA26
locus. In this transplantation scheme, ß-gal is only expressed when
the R26R and Alb-Cre alleles are combined in the same cell.
Hepatocytes were isolated from repopulated mice and found to
express ß-gal, conclusively showing that these cells were derived by
fusion between donor blood cells and host hepatocytes (Figure 3B).
Fusion-derived cells also expressed FAH, indicating the successful
activation of wild-type Fah supplied by donor hematopoietic cells
(Figure 3C).
Next, we examined reduction of DNA content and marker
segregation in fusion hepatocytes. Single cell hepatocyte suspen-
sions (containing a mixture of fusion-derived hepatocytes and host
hepatocytes) from repopulated mice were loaded with the DNA
dye Hoechst 33342 and analyzed by flow cytometry. In control
experiments, hepatocyte ploidy populations were readily identified
in non-transplanted mice (Figure S1A and S1B). As expected,
livers isolated from aged mice (Figure S1A) contained fewer
diploid hepatocytes than livers isolated from young mice (Figure
S1B). Furthermore, diploid hepatocytes were isolated with high
purity. Sorted 2n hepatocytes were .99% pure (Figure S1C), and
they contained a single Y-chromosome (Figure S1D). Analysis of
mice repopulated to ,40% by fusion hepatocytes revealed
populations of diploid and polyploid hepatocytes (Figure 3D).
The diffuse polyploid population is consistent with the chromo-
some distribution in Figure 1B. To utilize ß-gal as a marker of cell
fusion, hepatocytes were loaded with fluorescein di-ß-D-galacto-
pyranoside (FDG), a substrate that becomes fluorescent when
cleaved by the enzyme. As expected from the overall degree of
FAH repopulation, ß-gal was expressed by a fraction of polyploid
hepatocytes (27611% of all cells) (Figure 3E). Moreover,
interrogation of diploid hepatocytes revealed a subpopulation of
ß-gal positive cells (863% of all diploids). Hepatocyte populations
of different ploidy were also FACS-sorted and subjected to FAH
immunocytochemistry (Figure 3F). A portion of unfractionated
hepatocytes expressed FAH (3668%). Consistent with ß-gal
expression, a subpopulation of diploid hepatocytes also expressed
FAH (1063%). Together, these results show that fusion-derived
hepatocytes undergo ploidy reduction events, generating diploid
hepatocytes that express ß-gal and FAH.
Marker Loss in Reduced-Ploidy Daughter Cells
Although the mechanism by which fusion-derived hepatocytes
undergo ploidy reductions is unknown, the data clearly suggest a
model in which individual chromosomes/markers segregate
independently of one another. For example, as described in
Figure 3A, fusion between a donor diploid blood cell (female,
R26R
Tg/0, Fah
+/+) and recipient diploid hepatocyte (male, Alb-
Cre, Fah
2/2) generates a tetraploid cell containing a single Y-
chromosome and a single copy of R26R. The Alb-Cre genotyping
assay fails to distinguish between hemi- and homozygous mice.
Thus, tetraploid fusion-derived hepatocytes undergoing ploidy
reductions should generate a pair of diploid daughter cells, and
each daughter cell should have a 50% chance of inheriting either
R26R or the Y-chromosome.
We performed single cell genotyping of diploid hepatocytes to
determine whether chromosomes/markers were lost in cells that
had undergone ploidy reduction events. Hepatocytes from
repopulated livers (Figure 3A) were FACS-purified on the basis
Table 1. Karyotypes of fusion-derived hepatocytes.
Transplant Nearest Ploidy Chromosome Number Sex Chromosome Gain Chromosome Loss
Recipient #1 Diploid 40 XY 5, Mar1 17, 18
40 XY der(8), Mar1 18
Triploid 55 XY 11, 15, 19 1, 4, 5, 6, 8, 10, 14, X or Y
64 2X1Y 562, 9, 1262, 1562 6, 16, 19
67 2X1Y 10, 11, 12, 14, 15, 17, 18, 19 8
Tetraploid 79 3X1Y None 6
80 3X1Y None None
Hexaploid 108 3X1Y 12, Mar1, Mar2632 , 3 , 5 62, 662, 7, 862, 9, 10, 11, 14, 1662, X, Y
112 4X1Y 1562, 16, Mar1, Mar2 262, 363, 6, 1062, 11, 17, 1962, Y
117 4X1Y 8, 11, 12, 1962, Mar1, Mar2, Mar3 3, 4, 762, 962, 10, 13, 14, 15, Y
Recipient #2 Diploid 38 XY Mar1 1, 9, 14
40 XY 2, Mar1627 , 9 , 1 6
40 XY None None
Tetraploid 79 3X1Y 4, 18, Mar162 7, 8, 10, 12, 17
80 2X2Y 1, 3, 1863, 19626 , 7 , 8 62, 9, 1062
80 3X1Y 3, 8 4, 9
80 2X2Y 362, 4, 18, 19 5, 663, 10
82 3X1Y 13, 17, 1962, Mar1631 , 5 , 1 6 63
Hexaploid 117 5X1Y 11, 12, 1962, X, Mar163 1 ,2 ,5 ,6 ,1 0 ,1 3 62, 16, 1762, Y
122 4X2Y 1, 2, 1962, Mar1 6, 7, 15
Representative karyotypes of fusion-derived hepatocytes (Y-chromosome positive) from two independent serial transplant recipients (F.M.F). Chromosome gains and
losses are described relative to the nearest cell ploidy level.
doi:10.1371/journal.pgen.1000385.t001
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host (Cre and Y-chromosome) markers. One of the major
obstacles to single cell genotyping is PCR failure, resulting from
DNA degradation or template inaccessibility [18]. In our hands,
PCR failure ranged from 0 to 40%, which is consistent with
published rates [18]. To minimize the effects of PCR failure, each
marker was detected with two independent primer sets, thus
reducing the net dropout rate to 0% (Fah), 13.2% (R26R), 0.5%
(Cre) and 2.5% (Y-chromosome). As a control, single splenocytes
from repopulated mice were genotyped and found to contain only
host markers (cells 1 and 2) or donor markers (cells 3–5)
(Figure 4A). These results are consistent with a high degree of
donor engraftment seen in our KLS and bone marrow
transplanted mice (Duncan, Hickey and Grompe, unpublished
results).
Single cell genotyping was performed on 157 diploid hepato-
cytes derived from two independently transplanted mice. Repre-
sentative PCR data is shown (Figure 4B). Cell 7 contained only
host markers, suggesting that it was host-derived. Cell 1, which was
positive for all makers, was fusion-derived. All of the remaining
cells illustrated loss of one (cells 2 and 3) or more markers (cells 4–
6). Overall, Fah was detected in 29% of the cells. Detailed analysis
of the diploid Fah positive fusion products revealed that 57% lost
the R26R transgene, 33% lost the Cre transgene and 70% lost the
Y-chromosome (Figure 4C). Although PCR failure may account
for a small percentage of the observed marker loss, the high degree
of marker loss represents loss-of-heterozygosity at the indicated
locus. Furthermore, loss of one or more markers was identified in
subpopulations of diploid Fah positive hepatocytes (Figure 4D).
Only 13% of cells, for example, contained all four markers. Loss of
a single marker was detected in 13% (Y-chromosome) and 17%
(R26R) of the cells. Loss of two markers (R26R/Y-chromosome,
Cre/Y-chromosome) or three markers (R26R/Cre/Y-chromo-
some) was found in 24%, 17% and 15%, respectively, of diploid
hepatocytes. Together, these data showed that diploid daughter
cells were genetically unique, suggesting that autonomous markers
segregate independently during ploidy reduction events.
Discussion
In this study, we demonstrated that fusion-derived hepatocytes
could undergo ploidy reductions. Initially, serial transplantation
experiments were performed. Cytogenetic analysis showed that
14% of fusion-derived hepatocytes were nearly diploid. Surpris-
ingly, fusion-derived hepatocytes were highly aneuploid. While
most regenerating nodules expressed all markers of cell fusion, a
fraction of FAH positive nodules (2–5%) were Y-chromosome
negative or ß-gal negative. This frequency suggests that 4–10% of
the nodules were initiated by cells that had undergone ploidy
reduction events. Next, we utilized a ß-gal reporter system to track
fusion products in discrete ploidy populations. Polyploid hepato-
cytes expressed FAH (indicating that fusion-derived cells were
reprogrammed to express donor genes) and ß-gal (demonstrating
that these cells were derived by cell fusion). Significantly, diploid
hepatocytes also expressed ß-gal and FAH, establishing that these
cells originated from polyploid fusion-derived hepatocytes. Finally,
we carefully tracked donor/host markers in hepatocytes that had
undergone ploidy reductions by single cell genotyping. The
majority of diploid daughter hepatocytes (87%) were negative
for one or more markers, giving rise to a heterogeneous population
of cells. These results suggest that markers/chromosomes
segregate independently during ploidy reduction events.
Hepatocyte polyploidization has been documented in many
species (reviewed by Gupta [13]), but ploidy reversal has not been
rigorously characterized. Our experiments provide proof-of-
concept that ploidy reversal does occur in fusion-derived
hepatocytes. Several reports also suggest that normal hepatocytes
may undergo ploidy reduction. For instance, treatment of rodents
with hepatotoxins thioacetamide [19] and carbon tetrachloride
[20] led to a dramatic increase in diploid hepatocytes and
concomitant decrease in polyploid hepatocytes over 72 hr.
Differential proliferation and/or cell death was not seen among
diploid or polyploid hepatocytes [20]. Thus, it is possible that
normal polyploid hepatocytes undergo ploidy reductions, but this
hypothesis remains to be tested.
The high degree of aneuploidy displayed by fusion-derived
hepatocytes is surprising. It is unclear whether aneuploidy resulted
directly from the fusion and/or ploidy reduction events or
indirectly as a consequence of the Fah repopulation model [5].
Furthermore, we cannot exclude the possibility of stochastic
chromosome loss during mitosis [21]. Thus, aneuploid hepatocytes
could arise from the random loss of chromosomes by fusion-
derived hepatocytes undergoing extensive proliferation.
A number of possibilities could explain how diploid hepatocytes
are generated from polyploid fusion-derived hepatocytes. First, it is
theoretically possible that binucleated fusion-derived hepatocytes
could simply complete cytokinesis (Figure 5A). Normal binucleated
polyploid hepatocytes are formed through failed cytokinesis
[22,23]. For example, a mononucleated diploid hepatocyte
undergoes a regular mitosis, but then separation of the two
daughter cells fails, generating a binucleated tetraploid cell with
two diploid nuclei [22]. Whether binucleated hepatocytes could
resume cytokinesis is unclear, but it remains a possibility. In the
context of fusion-derived hepatocytes, the completion of cytoki-
nesis would generate two mononucleated diploid daughter cells,
each with the same genotype as the original fusion partners. As
seen in Figure 4D, subsets of diploid hepatocytes contained a
donor marker (Fah) and a recipient marker (Cre and/or Y-
chromosome), proving that these cells were genetically distinct
from the original fusion partners. Therefore, a cytokinesis-type
mechanism can be excluded.
The second possibility is chromosome loss via multipolar
mitosis, which can lead to the random segregation of chromosome
content among two or more daughter cells [24]. Fusion-derived
hepatocytes have increased numbers of centrosomes, which could
result in the formation of multiple spindle poles during prophase.
Thus, multipolar mitotic events could enrich for daughter cells
with diploid chromosome content (Figure 5B). However, multi-
polar mitosis cannot adequately explain the clustering of fusion-
derived hepatocytes with atypical chromosome counts. For
example, triploid hepatocytes with ,60 chromosomes (XXY or
Figure 2. Marker loss in livers repopulated with fusion-derived hepatocytes. (A–D) Marker analysis was performed on sequential liver
sections from serially transplanted mice. The transplantation scheme (F.M.Fo rM .F.F) is indicated. FAH+ nodules (brown) either co-expressed
the Y-chromosome (black dots) (A) or were devoid of Y-chromosome staining (B and C). Double asterisks (**) indicate double positive nodules (FAH+
and Y-chromosome+) whereas single asterisks (*) indicate single positive nodules (FAH+ and Y-chromosome2). (D) ß-gal (blue staining) is expressed
in a single FAH+ nodule but is absent from peripheral FAH+ tissue. Double diamonds (ee) indicate double positive tissue (FAH+ and ß-gal+) and
single diamonds (e) indicate a single positive nodule (FAH+ and ß-gal2). Scale bars are 200 mm. (E) Percentage of transplanted mice containing
FAH+ fusion-derived nodules that lack Y-chromosome or ß-gal is shown.
doi:10.1371/journal.pgen.1000385.g002
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PLoS Genetics | www.plosgenetics.org 6 February 2009 | Volume 5 | Issue 2 | e1000385Figure 3. Diploid hepatocytes express markers of cell fusion. (A) Transplantation scheme for detection of fusion-derived hepatocytes. Donor
bone marrow cells (from female transgenic mice hemizygous for R26R) were transplanted into lethally irradiated male Fah
2/2 mice containing the
Alb-Cre transgene. Following fusion between donor hematopoietic cells and host hepatocytes, loxP sites were excised by Cre recombinase, leading
to ß-gal expression via the ROSA26 promoter. (B and C) Hepatocytes from repopulated mice expressed ß-gal (blue, as seen by X-Gal staining) (B) and
FAH (red) (C). Scale bars are 100 mm (n=5). (D and E) Hepatocyte suspensions were loaded with Hoechst 33342 and FDG. Livers from repopulated
mice were comprised of diploid and polyploid hepatocytes (D). FACS analysis shows the ploidy distribution from a representative mouse (n=8). ß-gal
was expressed by a subset of each hepatocyte ploidy population (E). FACS analysis shows FDG expression by diploid, polyploid and unfractionated
hepatocytes from a representative liver (n=5). (F) FAH was expressed by unfractionated hepatocytes as well as FACS-sorted diploid hepatocytes.
Data represent percentage (average6SEM) of cells expressing FAH (n=4).
doi:10.1371/journal.pgen.1000385.g003
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These daughter cells likely originated from hexaploid fusion-
derived hepatocytes. It is difficult to imagine how multipolar
mitosis would enrich for cells with such abnormal chromosome
counts. Furthermore, if ploidy reduction were achieved by
multipolar mitosis, then each chromosome should be lost with
the same low frequency (i.e., 1/19 for autosomes). Single cell
genotyping of diploid daughter hepatocytes showed loss of R26R
(located on chromosome 6 [25]) and the Y-chromosome at 50% or
greater (Figure 4C). This high degree of marker segregation
strongly suggests that chromosome/marker loss occurs in a non-
random fashion.
Another possibility to explain the emergence of daughter
hepatocytes with one-half DNA content is cell division without
DNA replication (Figure 5C). This type of ploidy reduction was
first described in the mosquito Culex pipiens [26,27] but has never
been described in mammalian cells. In this model, fusion-derived
hepatocytes could proceed through G1 phase of the cell cycle, skip
S-phase and progress to G2/mitosis. Pairing between homologous
chromosomes would ensure proper chromosome segregation. This
type of mechanism accounts for the generation of diploid daughter
cells (Figures 1B, 3E and 3F) as well as enrichment for atypical
triploid daughter cells (Figure 1B). Moreover, the high degree of
marker loss seen in diploid daughter cells (Figure 4C) is possible
through a chromosome pairing interaction. Rigorous testing of all
potential mechanisms must be performed to elucidate the cellular
processes governing ploidy reductions in fusion-derived hepato-
cytes.
Finally, direct transmission of DNA via horizontal gene transfer
(HGT) into diploid hepatocytes must be considered. HGT among
somatic cells involves phagocytosis of apoptotic cells followed by
nuclear uptake/integration of whole chromosomes or chromo-
some fragments by the engulfing cell [28,29]. HGT was
hypothesized to induce hepatocyte reprogramming in xenotrans-
plantation experiments [30]. In our studies, diploid host
hepatocytes could acquire genes from apoptotic donor blood cells,
Figure 4. Fusion markers segregate independently in diploid daughter hepatocytes. FACS-isolated cell populations from mice
repopulated via the scheme in Figure 3A were genotyped by single cell PCR for donor (Fah and R26R) and host (Cre and Y-chromosome) markers.
Two primer sets per marker were utilized (i.e., primer sets ‘‘a’’ and ‘‘b’’). (A) Representative data for splenocytes is shown (n=100 cells from 4
repopulated mice). Cells 1 and 2 were positive for host markers and cells 3–5 were positive for donor markers. Negative control is marked ‘‘neg.’’ (B)
Representative data for diploid hepatocytes is shown (n=157 cells from 2 repopulated mice). Cell 1 was positive for all markers, whereas cell 7 was
positive for only recipient markers. Cells 2 and 3 were negative for the Y-chromosome and Cre transgene, respectively. An example of PCR failure is
shown for cell 2 (R26R). Although this cell was negative for R26R-a, it was positive for R26R-b. Therefore, cell 2 was scored ‘‘positive’’ for R26R. Losso f
two or more markers was seen in cell 4 (R26R/Y-chromosome), cell 5 (Cre/Y-chromosome) and cell 6 (R26R/Cre/Y-chromosome). (C and D) Fah+
diploid hepatocytes were genotyped (n=44 cells from two mice). The percentage of single cells that lost R26R, Cre and the Y-chromosome is
compared to the calculated PCR failure rate for each marker (C). *, P=0.006; ** P,0.0001. The presence (shaded boxes) and absence (white boxes) of
donor and host markers is shown for each subpopulation (D). The percentage of each subpopulation is indicated.
doi:10.1371/journal.pgen.1000385.g004
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diploid chromosome count (Figure 5D). However, the presence of
multiple donor markers on different chromosomes by HGT is
expected to be rare, and we found that nearly half of diploid
fusion-derived hepatocytes harbored at least two donor markers
(Figure 4D). Therefore, our data strongly argue against an HGT-
type of mechanism.
Regardless of the mechanism, ploidy reduction events have
significant implications. In the context of fusion-derived hepato-
cytes, ploidy reductions can be a confounding factor when tracing
markers during stem cell transplantation. Donor markers can be
lost during ploidy reductions, thus leading to an underestimate of
engraftment. Similarly, host markers can be lost from hybrids,
obscuring the existence of fusion and giving the false impression of
transdifferentiation. Because cell fusion between transplanted cell
types and target organs has been described in many experimental
systems (reviewed in [31]), the possibility of ploidy reductions
needs to be considered when interpreting cell transplantation
experiments. Furthermore, we propose that ploidy reduction
events may contribute to tumorigenesis. The independent
Figure 5. Potential mechanisms for diploid hepatocyte formation from polyploid fusion-derived hepatocytes. (A) Cytokinesis without
mitosis. A binucleated cell undergoes cytokinesis before entering the next cell cycle. This process would not produce marker loss or aneuploidy. (B)
Multiple spindles, followed by multipolar (in this case tetrapolar) mitosis. Extreme aneuploidy would result. (C) Mitosis without S-phase with
chromosome pairing. This would ensure proper chromosome segregation and would facilitate distribution of hemizygous markers between daughter
cells. (D) Horizontal gene transfer. A diploid cell engulfs a neighboring cell undergoing apoptosis. Single chromosomes and/or chromosome
fragments would be incorporated into the nucleus while maintaining a nearly diploid karyotype. The parental cell is shown at left, mitotic spindle(s)
(when necessary) in the middle and resulting diploid cells on the right. Open circles represent centromeres. Black circles represent centrosomes.
Chromosomes are shown in different colors to indicate their lineage. Host hepatocyte chromosomes are red, and donor chromosomes are blue.
doi:10.1371/journal.pgen.1000385.g005
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genetically heterogeneous diploid daughter hepatocytes. Individ-
ual daughter cells could lose tumor suppressors, generating a
subset of hepatocytes with oncogenic potential.
Methods
Ethics Statement
The Institutional Animal Care and Use Committee of the
Oregon Health and Science University approved all mouse
experiments.
Mice
The following inbred mouse strains were used: wild-type (C57Bl
and 129), transgenic ROSA26 (C57Bl and 129) [32], Fah
2/2
(C57Bl and 129) [33], transgenic R26R-lacZ C57Bl [34],
transgenic Albumin-Cre C57Bl [35].
Cell Isolation and Sorting
KLS cells were sorted from mouse bone marrow, as described
[36]. Antibodies used for cell sorting are described in Protocol S1.
Primary hepatocytes were isolated by two-step collagenase
perfusion [4] and cultured hepatocytes were isolated by trypsin-
ization. For detection of hepatocyte ploidy populations, hepato-
cytes (2610
6/ml) were incubated with 15 mg/ml Hoechst 33342
(Sigma) and 5 mM reserpine (Invitrogen) for 30 min at 37u. Cells
were analyzed and/or sorted with an InFlux flow cytometer
(Cytopeia) using a 150 mm nozzle. Dead cells were excluded on
the basis of 5 mg/ml propidium iodide (Invitrogen) incorporation.
Cells adhering to each other (i.e., doublets) were eliminated on the
basis on pulse width. Ploidy populations were identified by DNA
content using an ultraviolet 355 nm laser and 425–40 nm
bandpass filter. Sorted hepatocytes were collected in DMEM with
4.5 g/l glucose (HyClone) containing 50% fetal bovine serum
(FBS) (HyClone). The purity of sorted populations was determined
at the end of each sort, and only highly purified populations
(.99% pure) were used for subsequent assays.
Transplantation
Transplantation of hematopoietic cells (either bone marrow or
KLS cells) was performed as previously described [1,12]. Briefly,
hematopoietic cells (either 4610
6 bone marrow cells or 3–4610
3
KLS cells) were injected retro-orbitally into groups of congenic
Fah
2/2 recipient mice. KLS cells were co-transplanted along with
3610
5 bone marrow cells derived from an unirradiated recipient
mouse. Host mice were lethally irradiated with 12 Gy using a
137Cs irradiator 4–24 hr prior to transplantation, obtained by two
doses of 6 Gy each. Mice were maintained on NTBC drinking
water (8 mg/ml). NTBC was withdrawn 3–12 weeks post
transplantation, providing a selective environment for the
proliferation of FAH positive fusion-derived hepatocytes.
For serial transplantation experiments, hepatocytes were
isolated from primary transplanted mice and 1–3610
5 cells
injected intrasplenically into Fah
2/2 recipient mice. NTBC was
stopped immediately, allowing for selection of FAH positive cells
[3].
Cytogenetics
Freshly isolated primary hepatocytes were seeded at 1–2610
3
cells/cm
2 on Primaria tissue culture plastic (Beckton Dickinson).
Cells were incubated in hepatocyte culture medium containing
DMEM with 4.5 g/l glucose (HyClone), 10% FBS (HyClone),
nonessential amino acids (Cellgro) and antibiotic-antimycotic
(Cellgro). Nonadherent cells were removed after 4 hr. Hepatocytes
were then incubated in culture medium supplemented with
100 ng/ml human epidermal growth factor (Invitrogen) plus
insulin, transferrin, selenium and ethanolamine (ITS-X, Invitro-
gen). After ,40 hr, hepatocytes were treated with 150 mg/ml
colcemid (Sigma) for 2–4 hr and harvested by trypsinization. After
extensive washing, slides were incubated for 10 min in 56 mM
KCl with 5% FBS and fixed with methanol:acetic acid (3:1 ratio).
For karyotype analysis, chromosomes were G-banded with a
standard trypsin/Wright’s stain protocol. Fluorescent in situ
hybridization on interphase hepatocytes was performed using a
Cy3-labeled whole chromosome paint (mouse Y-chromosome) per
manufacturer’s instructions (Cambio).
Histology and Immunocytochemistry
Histological analyses were performed as described [3]. For FAH
immunocytochemistry, hepatocytes (either unfractionated or
FACS-purified) were allowed to adhere to collagen-coated Lab-
Tek II, CC2-treated chamber slides (Nunc) in hepatocyte culture
medium for 24 hr. Slides were washed extensively, fixed with
methanol and dehydrated with acetone. After blocking in 5%
normal donkey serum, cells were incubated with a custom rabbit
polyclonal FAH antibody diluted 1:1000 and detected with 10 ng/
ml donkey anti-rabbit secondary antibody conjugated to Alexa-
fluor 555 (Invitrogen). Nuclei were visualized with 200 ng/ml
Hoechst 33342. For detection of ß-gal activity, hepatocytes were
plated in culture medium on Primaria plastic. After 24 hr,
adherent hepatocytes were subjected to X-Gal (5-bromo-4-
chloro-3-indolyl-ß-D-galactopyranoside, Invitrogen) staining as
described [37]. Alternatively, flow cytometry was used to detect
ß-gal activity in Hoechst-stained hepatocytes (for the detection of
ploidy populations) using FDG reagent (Invitrogen) per manufac-
turer’s instructions.
Single-Cell PCR
Single hepatocytes or splenocytes were FACS-sorted into
individual wells of a 96-well PCR plate, lysed and subjected to
semi-nested PCR, as described in Protocol S2.
Statistical Analysis
Fisher’s exact test (two-sided) was used to determine statistical
significance. P values less than 0.05 were considered statistically
significant.
Supporting Information
Figure S1 Hepatocytes are FACS-isolated with high purity. (A
and B) Hepatocytes isolated from 4 month old (A) and 20 day
old (B) male non-transplanted mice were loaded with Hoechst
33342 and analyzed by flow cytometry. FACS plots show
representative ploidy distributions (n.10 for 3–5 month old
mice; n=3 for 20 day old mice). (C and D) Purity of FACS-
isolated diploid hepatocytes (from the 20 day old mouse) was
evaluated. Sorted diploid hepatocytes were .99% pure, as
detected by FACS (n.10) (C). All sorted diploid hepatocytes
contained a single Y-chromosome (red), which is expected for
diploid male cells (D). Nuclei are shown in blue. Scale bar is
20 mm (n=5).
Found at: doi:10.1371/journal.pgen.1000385.s001 (0.34 MB TIF)
Protocol S1 KLS cell sorting from mouse bone marrow.
Found at: doi:10.1371/journal.pgen.1000385.s002 (0.03 MB PDF)
Protocol S2 Single cell PCR.
Found at: doi:10.1371/journal.pgen.1000385.s003 (0.09 MB PDF)
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